Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05379101 · ClinicalTrials.gov registry record
Intracardiac Flow Assessment in Cardiac Amyloidosis
A clinical trial of Healthy Adults and Amyloidosis Cardiac, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05379101: Recruiting study of Healthy Adults and Amyloidosis Cardiac, sponsored by Mayo Clinic.
NCT05379101 is a study of Healthy Adults and Amyloidosis Cardiac that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 100 participants, above the 83-participant average among 33 other Healthy Adults trials with a reported enrollment target (20% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05379101, a study of Healthy Adults and Amyloidosis Cardiac, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.
Primary Outcome
Measured by cardiac magnetic resonance imaging (CMR)
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac magnetic resonance image (CMR)
- DIAGNOSTIC_TEST Transthoracic Echocardiogram (TTE)
- DIAGNOSTIC_TEST Six-minute Walk Test
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2026-06 |
What NCT05379101 shows while recruiting
NCT05379101 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, above the 83-participant average among 33 other Healthy Adults trials with a reported enrollment target (20% higher).
The record links to 2 conditions, with Healthy Adults appearing as the primary indexed condition, and to 3 interventions - of which Cardiac magnetic resonance image (CMR) is the first listed.
NCT05379101 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05379101 about?
NCT05379101 is a clinical study titled "Intracardiac Flow Assessment in Cardiac Amyloidosis". The primary objective of this study is to define the intracardiac flow imaging biomarkers in cardiac amyloidosis.
What is the current status of trial NCT05379101?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-07-20. Estimated completion is 2026-06.
What conditions does trial NCT05379101 study?
This clinical trial studies the following conditions: Healthy Adults, Amyloidosis Cardiac.
What interventions are being tested in trial NCT05379101?
The interventions under investigation include: Cardiac magnetic resonance image (CMR) (DIAGNOSTIC_TEST), Transthoracic Echocardiogram (TTE) (DIAGNOSTIC_TEST), Six-minute Walk Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05379101?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05379101 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Adults
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05379101's enrollment target sits among peer trials
100 6th of 33 higher than 27 of 33 other Healthy Adults trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Adults trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Breathing Training and Nitrate on Exercise at Simulated Altitude
RECRUITING · NA
-
Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
RECRUITING · NA
-
A Study of EDG-15400 in Healthy Adults
RECRUITING · Phase 1
-
A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060
RECRUITING · Phase 1
-
Health Properties of Pecan Nut Consumption
RECRUITING · NA
-
The Brain Processes Underlying Speech Motor Learning and Speech Production
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI